Allogene Therapeutics, Inc. (ALLO) Reports In-Line Q2 EPS

Go back to Allogene Therapeutics, Inc. (ALLO) Reports In-Line Q2 EPS
(NASDAQ: ALLO) Delayed: 2.12 +0.02 (0.95%)
Previous Close $2.10    52 Week High
Open $2.11    52 Week Low
Day High $2.19    P/E N/A 
Day Low $2.07    EPS
Volume 4,957,303